169 related articles for article (PubMed ID: 24379381)
1. Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists.
Jaszberenyi M; Rick FG; Popovics P; Block NL; Zarandi M; Cai RZ; Vidaurre I; Szalontay L; Jayakumar AR; Schally AV
Proc Natl Acad Sci U S A; 2014 Jan; 111(2):781-6. PubMed ID: 24379381
[TBL] [Abstract][Full Text] [Related]
2. Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro.
Jaszberenyi M; Schally AV; Block NL; Zarandi M; Cai RZ; Vidaurre I; Szalontay L; Jayakumar AR; Rick FG
Target Oncol; 2013 Dec; 8(4):281-90. PubMed ID: 23371031
[TBL] [Abstract][Full Text] [Related]
3. Protection of neonatal rat cardiac myocytes against radiation-induced damage with agonists of growth hormone-releasing hormone.
Kiscsatári L; Varga Z; Schally AV; Gáspár R; Nagy CT; Giricz Z; Ferdinandy P; Fábián G; Kahán Z; Görbe A
Pharmacol Res; 2016 Sep; 111():859-866. PubMed ID: 27480202
[TBL] [Abstract][Full Text] [Related]
4. Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI).
Kanashiro-Takeuchi RM; Takeuchi LM; Rick FG; Dulce R; Treuer AV; Florea V; Rodrigues CO; Paulino EC; Hatzistergos KE; Selem SM; Gonzalez DR; Block NL; Schally AV; Hare JM
Proc Natl Acad Sci U S A; 2012 Jan; 109(2):559-63. PubMed ID: 22203988
[TBL] [Abstract][Full Text] [Related]
5. Direct action of growth hormone-releasing hormone agonist JI-38 on normal human fibroblasts: evidence from studies on cell proliferation and c-myc proto-oncogene expression.
Kiaris H; Schally AV; Armatis P
Regul Pept; 2001 Jan; 96(3):119-24. PubMed ID: 11111017
[TBL] [Abstract][Full Text] [Related]
6. Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival.
Florea V; Majid SS; Kanashiro-Takeuchi RM; Cai RZ; Block NL; Schally AV; Hare JM; Rodrigues CO
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17260-5. PubMed ID: 25404316
[TBL] [Abstract][Full Text] [Related]
7. Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH.
Schally AV; Wang H; He J; Cai R; Sha W; Popovics P; Perez R; Vidaurre I; Zhang X
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):12028-12033. PubMed ID: 30373845
[TBL] [Abstract][Full Text] [Related]
8. Acceleration of wound healing by growth hormone-releasing hormone and its agonists.
Dioufa N; Schally AV; Chatzistamou I; Moustou E; Block NL; Owens GK; Papavassiliou AG; Kiaris H
Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18611-5. PubMed ID: 20937882
[TBL] [Abstract][Full Text] [Related]
9. Effects of growth hormone-releasing hormone and its agonistic and antagonistic analogs in cancer and non-cancerous cell lines.
Barabutis N; Siejka A; Schally AV
Int J Oncol; 2010 May; 36(5):1285-9. PubMed ID: 20372804
[TBL] [Abstract][Full Text] [Related]
10. Profound Actions of an Agonist of Growth Hormone-Releasing Hormone on Angiogenic Therapy by Mesenchymal Stem Cells.
Ma Q; Xia X; Tao Q; Lu K; Shen J; Xu Q; Hu X; Tang Y; Block NL; Webster KA; Schally AV; Wang J; Yu H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):663-672. PubMed ID: 26868211
[TBL] [Abstract][Full Text] [Related]
11. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers.
Stangelberger A; Schally AV; Varga JL; Hammann BD; Groot K; Halmos G; Cai RZ; Zarandi M
Prostate; 2005 Aug; 64(3):303-15. PubMed ID: 15754342
[TBL] [Abstract][Full Text] [Related]
12. Potentiating effects of GHRH analogs on the response to chemotherapy.
Schally AV; Perez R; Block NL; Rick FG
Cell Cycle; 2015; 14(5):699-704. PubMed ID: 25648497
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction.
Kanashiro-Takeuchi RM; Tziomalos K; Takeuchi LM; Treuer AV; Lamirault G; Dulce R; Hurtado M; Song Y; Block NL; Rick F; Klukovits A; Hu Q; Varga JL; Schally AV; Hare JM
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2604-9. PubMed ID: 20133784
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone.
Jaszberenyi M; Schally AV; Block NL; Nadji M; Vidaurre I; Szalontay L; Rick FG
Oncotarget; 2013 Mar; 4(3):422-32. PubMed ID: 23518876
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of antagonists of growth hormone-releasing hormone on growth and invasiveness of PC3 human prostate cancer.
Muñoz-Moreno L; Arenas MI; Schally AV; Fernández-Martínez AB; Zarka E; González-Santander M; Carmena MJ; Vacas E; Prieto JC; Bajo AM
Int J Cancer; 2013 Feb; 132(4):755-65. PubMed ID: 22777643
[TBL] [Abstract][Full Text] [Related]
16. Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice.
Chatzistamou I; Schally AV; Varga JL; Groot K; Armatis P; Busto R; Halmos G
J Clin Endocrinol Metab; 2001 May; 86(5):2144-52. PubMed ID: 11344219
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities.
Cai R; Schally AV; Cui T; Szalontay L; Halmos G; Sha W; Kovacs M; Jaszberenyi M; He J; Rick FG; Popovics P; Kanashiro-Takeuchi R; Hare JM; Block NL; Zarandi M
Peptides; 2014 Feb; 52():104-12. PubMed ID: 24373935
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways.
Plonowski A; Schally AV; Varga JL; Rekasi Z; Hebert F; Halmos G; Groot K
Prostate; 2000 Jul; 44(2):172-80. PubMed ID: 10881027
[TBL] [Abstract][Full Text] [Related]
19. Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer.
Muñoz-Moreno L; Arenas MI; Carmena MJ; Schally AV; Sánchez-Chapado M; Prieto JC; Bajo AM
Oncotarget; 2016 Aug; 7(32):52195-52206. PubMed ID: 27448980
[TBL] [Abstract][Full Text] [Related]
20. Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.
Szalontay L; Schally AV; Popovics P; Vidaurre I; Krishan A; Zarandi M; Cai RZ; Klukovits A; Block NL; Rick FG
Cell Cycle; 2014; 13(17):2790-7. PubMed ID: 25486366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
